Conversely, AKT blockage or preventing miRNA-PTEN interaction can inhibit ovarian cancer, apoptosis, the induction of cancer cell proliferation, and chemotherapeutic drug tolerance. The gene discussed is AKT1; the disease is ovarian carcinoma.